The Lancet | Hepatitis B reactivation after chemoimmunotherapy: screen before treatment. @TheLancetTV | Uploaded February 2021 | Updated October 2024, 8 minutes ago.
Screening for hepatitis B in patients on rituximab and other anti-CD20 treatments.

Read the full clinical picture, Hepatitis B reactivation after chemoimmunotherapy: screen before treatment, at thelancet.com/journals/lancet/article/PIIS0140-6736(21)00210-5/fulltext?dgcid=youtube_video_lancet_clinpic

Visit The Lancet at thelancet.com/?dgcid=youtube_video_lancet_clinpic

* * *
Continue this conversation on social! Follow us today at…
Twitter.com/TheLancet
Facebook.com/TheLancetMedicalJournal
Instagram.com/TheLancetGroup
LinkedIn.com/company/The-Lancet